Bhopal Scientists Develop India’s First Indigenous H5N1 Bird Flu Vaccine

bird flu


Bhopal: Researchers in Bhopal have created India’s first homegrown vaccine to shield poultry farms and the broader industry from the deadly H5N1 avian influenza virus.

Developed by the National Institute of High Security Animal Diseases (ICAR-NIHSAD)—which operates under the Indian Council of Agricultural Research (ICAR)—this vaccine specifically targets viral clade 2.3.2.1a. Union Agriculture Minister Shivraj Singh Chouhan is scheduled to officially unveil the vaccine at the institute’s Bhopal campus on November 20.

Designed as an inactivated vaccine, it is projected to immunize chickens for up to six months with just a single shot. Following promising trial outcomes in laying hens and breeder flocks, commercial farms will deploy it primarily to protect these specific bird populations. Prior to this breakthrough, India lacked any commercially approved domestic vaccine tailored to this particular viral strain.

Protecting Long-Lived Flocks and Farm Livelihoods

For chickens, the H5N1 virus is devastatingly fatal and capable of wiping out nearly an entire flock once a farm is infected. Containing these outbreaks typically forces authorities to cull massive numbers of birds in surrounding areas, triggering severe economic setbacks for both farmers and poultry enterprises. Since India recorded its initial bird flu outbreak in 2006—an event that alone cost the industry an estimated ₹2,200 crore to ₹3,000 crore—over 500 cases have been documented nationwide.

Layer hens, which are raised for eggs, and breeder birds, maintained for reproduction, stand to gain the greatest advantage from this immunization. Because both groups live significantly longer than broiler chickens, sustained immunity is critical. Offering six months of coverage from a single dose also minimizes the operational burden of frequent booster shots.

Phased Rollout Under Veterinary Oversight

The vaccine will be rolled out across commercial poultry farms in structured phases. Trained personnel and veterinarians will oversee the administration of every dose, ensuring strict adherence to established medical protocols.

Tailored Specifically for India’s Viral Strain

While nations like China, Egypt, and Vietnam have previously produced bird flu vaccines, their formulations were engineered to combat the distinct viral clades circulating within their own borders. Because H5N1 clade 2.3.2.1a has presented a persistent threat to Indian poultry, Bhopal scientists formulated this indigenous solution to match the local strain directly.

Curbing Poultry Outbreaks Lowers Human Health Risks

Beyond devastating flocks, the H5N1 virus poses a zoonotic threat, capable of jumping to humans who come into close contact with infected birds. Human infections can lead to severe pneumonia, respiratory distress, and high fever. Data from the World Health Organization indicates that 1,003 human H5N1 cases have been recorded globally since 2003, claiming 479 lives. While curbing the virus within poultry populations should help lower the chances of human transmission, consistent surveillance, strict farm biosecurity, and avoiding contact with sick birds remain vital safeguards.



Exit mobile version